TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma

SIMPLE SUMMARY: Technical advances in immunotherapies have led to the development of novel T cell receptor (TCR)-based approaches to fight cancer. One of these therapies, tebentafusp, has shown a significant benefit in the overall survival of uveal melanoma patients for the first time. This review f...

Descripción completa

Detalles Bibliográficos
Autores principales: Strobel, Sophia B., Machiraju, Devayani, Hassel, Jessica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909175/
https://www.ncbi.nlm.nih.gov/pubmed/35267523
http://dx.doi.org/10.3390/cancers14051215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909175/
https://www.ncbi.nlm.nih.gov/pubmed/35267523
http://dx.doi.org/10.3390/cancers14051215

Ejemplares similares